Why the Blackmores share price is in a trading halt

The Blackmores Limited (ASX:BKL) share price is in a trading halt this morning after launching a capital raising. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Blackmores Limited (ASX: BKL) share price won't be going anywhere on Wednesday.

This morning the health supplements company requested that its shares be placed into a trading halt.

Why are Blackmores' shares in a trading halt?

Blackmores requested a trading halt this morning while it undertakes a capital raising which aims to raise up to $117 million.

According to the release, Blackmores' capital raising comprises a fully underwritten $92 million institutional placement and non-underwritten share purchase plan of up to $25 million.

Blackmores Chief Executive Officer, Alastair Symington, expects the capital raising to support its activities in the Asia market.

He explained: "The Equity Raise will strengthen Blackmores' balance sheet and liquidity position and provide the flexibility to pursue our key strategic priorities. It will enable us to accelerate our growth initiatives in Asia and invest in our efficiency program which will help us to achieve our objective of returning Blackmores to sustainable, profitable growth."

Trading update.

The company also provided the market with an update on how it is performing during the pandemic.

Blackmores advised that it has experienced a material increase in demand for its immunity products. However, as immunity products constitute only a small part of its portfolio, it isn't having a major impact on its performance.

Furthermore, any of the benefits it is experiencing from the surge in demand for immunity products, is being offset elsewhere in the business.

Management notes that there has been a lag in non-immunity products, which has been partly driven by lower shopping traffic.

Also weighing on its performance has been issues gaining access to some overseas sourced materials and capacity constraints at some contract manufacturers. These have prevented the company from being able to fully meet demand in some products.

In light of this, the company expects to deliver underlying net profit after tax of $17 million to $21 million in FY 2020. This is in-line with the guidance it provided with its first half results in February.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Capital Raising

Close-up photo of a human hand with $100 bills offering the money to another human hand.
Capital Raising

Why this ASX energy stock just crashed 17% after a blockbuster year

A major capital raise sends Tamboran shares down 17%.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Capital Raising

This ASX mining stock just banked $50 million. So why are its shares falling?

Dateline shares fall after a $50 million raise despite its Colosseum progress.

Read more »

Close-up photo of a human hand with $100 bills offering the money to another human hand.
Capital Raising

Why Magellan shares are rising again after its $20 million raise was swamped

Magellan shares edge higher as investors strongly back the latest capital raising.

Read more »

A man looking at his laptop and thinking.
Materials Shares

Core Lithium shares tumble after $120m capital raising for Finniss restart

It won't be long until the company is producing lithium again.

Read more »

Close-up photo of a human hand with $100 bills offering the money to another human hand.
Capital Raising

Why this ASX healthcare stock has crashed 20% today

The Imugene share price is plunging after announcing a heavily discounted capital raising.

Read more »

A man using a phone shouts and puts his hand out in a stop motion indicating the Yancoal trading halt today
Capital Raising

Magellan requests trading halt ahead of major announcement

Magellan enters a trading halt ahead of a proposed merger and capital raising.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Capital Raising

Why is this ASX 300 stock crashing 40% today?

Let's see why this stock is crashing deep into the red.

Read more »

A piggy bank is surround by hands preparing to pay coins into the slot, representing a company capital raisingh in asx share price represented by multiple hands all placing coins in a piggy bank
Capital Raising

Santana share price back in trade and down 12%. Here's what just happened

Santana shares tumble 12% after announcing a $130 million capital raise.

Read more »